Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track ELVN — free
$41.52 -0.41 (-0.98%) At close · Oct 23
Market Cap
$3.04B
Shares
73.27M
Volume · Oct 23 2.3M Avg daily vol (3M) 1.27M

Enliven Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Enliven Therapeutics, Inc. (ELVN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-06-04
Enliven Therapeutics, Inc. (ELVN) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-27
Enliven Therapeutics, Inc. (ELVN) Q1 2026 Earnings Call
Diluted EPS
$-0.38
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-12
Enliven Therapeutics, Inc. (ELVN) Q3 2025 Earnings Call
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-13
Enliven Therapeutics, Inc. (ELVN) Q1 2025 Earnings Call
Diluted EPS
$-0.57
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-04-11
Enliven Therapeutics, Inc. (ELVN) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-03-15
Enliven Therapeutics, Inc. (ELVN) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Enliven Therapeutics, Inc. (ELVN) Q3 2021 Earnings Call
Diluted EPS
$-0.74
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Enliven Therapeutics, Inc. (ELVN) Q2 2021 Earnings Call
Diluted EPS
$-0.74
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Enliven Therapeutics, Inc. (ELVN) Q1 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-05
Enliven Therapeutics, Inc. (ELVN) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Enliven Therapeutics, Inc. (ELVN) Q3 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-14
Enliven Therapeutics, Inc. (ELVN) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–12 of 12 webcasts
Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 14 filings 14 filers Visit website Investor relations